Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to uncover hidden viral threats in seniors

NCT ID NCT07539103

Knowledge-focused Sponsor: Gérond'if Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will look at 5,900 hospitalized adults aged 60 and older to find out which viruses cause severe lung infections. Researchers will test respiratory samples to track common and emerging viruses like flu, RSV, and COVID-19. The goal is to better understand how often these infections occur and how they affect older people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,900 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Hospitalized older patients (≥60 years old) tested for PCR as part of standard of care (SoC). Subjects meeting the eligibility criteria will be invited to participate in the study.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hospitalized subjects aged ≥ 60 years * A respiratory sample collected and tested by polymerase chain reaction (PCR) during hospitalisation as part of standard of care Note: Reasons for PCR: 1. Patients with Severe acute respiratory infection (SARI) 2. Patients with symptoms other than SARI 3. Systematic PCR testing (in the context of clusters or during the winter season) \* Recent onset of at least one general symptom and at least one functional or physical respiratory sign * General symptoms: fever (which may be absent in older patients), chills, sweating, headache, malaise, myalgia, arthralgia, fatigue, decline in general condition (asthenia, weight loss, anorexia, confusion, or dizziness), digestive disturbances. * Respiratory signs: sore throat, rhinorrhoea (common cold), cough, wheezing, dyspnoea, chest pain, or recent auscultatory abnormalities (diffuse or focal). * Subjects willing to participate, with a non-opposition form completed and signed by the qualified and trained healthcare professional responsible for providing the participant information * Subject affiliated to a health insurance system Exclusion Criteria: * Subjects refusing to participate * Subjects admitted to palliative care unit. * Subjects under guardianship * Any condition that, in the opinion of the investigator, may interfere with the aim of the study or wellbeing of the patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Viral pulmonary infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

viral pneumonia viral respiratory tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Viral pulmonary infections

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    20 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH de Versailles

    Le Chesnay, Île-de-France Region, 78157, France

  • CHU Amiens Picardie

    Amiens, 80054, France

  • CHU Bordeaux

    Pessac, Bordeaux, 33604, France

  • CHU Nimes

    Nîmes, 30029, France

  • Centre Hospitalier Départemental Vendée_La Roche sur Yon

    La Roche-sur-Yon, 85925, France

  • HEGP

    Paris, Île-de-France Region, 75015, France

  • Hôpital Ambroise Paré-APHP

    Boulogne-Billancourt, Île-de-France Region, 92100, France

  • Hôpital Avicenne APHP

    Bobigny, Île-de-France Region, 93000, France

  • Hôpital Bichat-APHP

    Paris, Île-de-France Region, 75877, France

  • Hôpital Bretonneau APHP

    Paris, Île-de-France Region, 75016, France

  • Hôpital Broca - APHP

    Paris, France

  • Hôpital Charles Foix APHP

    Ivry-sur-Seine, Île-de-France Region, 94200, France

  • Hôpital Corentin Celton APHP, Gérontologie 1

    Issy-les-Moulineaux, Île-de-France Region, 92130, France

  • Hôpital Corentin Celton APHP, Gérontologie 2

    Issy-les-Moulineaux, Île-de-France Region, 92130, France

  • Hôpital Emile Roux APHP

    Limeil-Brévannes, Île-de-France Region, 94450, France

  • Hôpital Henri Mondor APHP

    Créteil, Île-de-France Region, 94010, France

  • Hôpital Lariboisière - APHP

    Paris, Île-de-France Region, 75475, France

  • Hôpital Paul Brousse APHP

    Villejuif, Île-de-France Region, 94800, France

  • Hôpital Sainte Périne

    Paris, Île-de-France Region, 75016, France

  • Hôpital St Antoine

    Paris, 75012, France